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Abstract
Background: Studies evaluating collaborative care for anxiety disorders are recently emerging. A systematic review
and meta-analysis to estimate the effect of collaborative care for adult patients with anxiety disorders in primary
care is therefore warranted.
Methods: A literature search was performed. Data sources: PubMed, Psycinfo, Embase, Cinahl, and the Cochrane library.
Study eligibility criteria: Randomized controlled trials examining the effects of collaborative care for adult primary care
patients with an anxiety disorder, compared to care as usual or another intervention. Synthesis methods: Standardized
mean differences (SMD) on an anxiety scale closest to twelve months follow-up were calculated and pooled in a random
effects meta-analysis.
Results: Of the 3073 studies found, seven studies were included with a total of 2105 participants. Included studies
were of moderate to high quality. Collaborative care was superior to care as usual, with a small effect size (SMD= 0.35
95 % CI 0.14–0.56) for all anxiety disorders combined and a moderate effect size (SMD= 0.59, 95 % CI 0.41–0.78) in a
subgroup analysis (five studies) on patients with panic disorder.
Conclusions: Collaborative care seems to be a promising strategy for improving primary care for anxiety disorders, in
particular panic disorder. However, the number of studies is still small and further research is needed to evaluate the
effectiveness in other anxiety disorders.
Keywords: Collaborative care, Primary care, Anxiety disorders, Systematic review, Meta-analysis, Randomized controlled
trials
Background
Anxiety disorders constitute the most prevalent category of
psychiatric disorders [1]. Anxiety disorders have a negative
impact on quality of life and are associated with significant
healthcare- and productivity costs [2]. Adults with an anx-
iety disorder mainly receive care in primary care [3–5]. In
many countries however, the quality of care for adults with
anxiety disorders leaves room for improvement [4, 6].
Although clinical guidelines recommend cognitive behav-
ioral therapy (CBT) or antidepressant medication as the
treatment of choice in primary care, these evidence-
based treatments are not often adequately applied in
primary care [7].
Several barriers still exist in providing evidence-based
care for anxiety disorders in primary care, which may be
related to patient characteristics, provider characteristics or
the organizational context of primary care [8–11]. There-
fore, multifaceted interventions that focus on patient,
provider and organization of care have been proposed as
the most promising strategy to improve primary mental
healthcare [12, 13]. Collaborative care models are such
multifaceted interventions, bringing mental health expertise
into primary care by introducing new members into the
primary care team. Typically, this new member is a “care
manager” - a mental health professional who coordinates
care, provides evidence-based interventions, and actively
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monitors the patients’ symptoms [14]. The care man-
ager usually is a non-physician professional, such as a
psychologist, a social worker or a psychiatric nurse.
The care manager works in close collaboration with the
primary care physician and preferably providers have
access to the tailored advice of a psychiatrist. Collab-
orative care models often vary in types of interventions
used, the intensity of treatment, collaboration, and
follow-up [15]. However, some essential elements have
been described by experts and in systematic reviews,
which consider cooperation between the primary care
physician and at least one other professional, provision
of evidence-based treatment, and active monitoring of
symptoms [14, 16–18]. Interventions or organizational
models similar to collaborative care are sometimes re-
ferred to as integrated care, enhanced care, or care
management.
Rationale
Previous reviews on collaborative care included only a
limited number of studies on anxiety disorders (4 in the
review of Archer and colleagues [19] and 3 in the re-
view of Woltmann and colleagues [20]). Furthermore,
all of these studies were conducted in the United States,
which may limit generalizability to primary care in
other countries. We are furthermore aware of recent
studies [21, 22] in other countries, so we systematically
reviewed the literature on collaborative (primary) care
for anxiety disorders, again.
Evidence of the effectiveness of collaborative care in
the treatment of depression is well established and
was reviewed thoroughly in several meta-analyses [19,
20, 23, 24]. The field has progressed to identifying el-
ements of collaborative care that contribute most to
its effectiveness. Recently, Coventry and colleagues
[25] concluded that the provision of a psychological
intervention increases the effectiveness of collabora-
tive care based on a meta-regression. We were curi-
ous to what extent and how this could also apply to
anxiety disorders.
Objectives
We performed a systematic review and meta-analysis
to summarize results from randomized controlled tri-
als about the effectiveness of collaborative care for
anxiety disorders in adult primary care patients com-
pared to care as usual. In addition, we evaluated the
effects for specific anxiety disorders and the influence
of several characteristics of study procedures and col-
laborative care interventions on the effectiveness of
the collaborative care model. We used the PRISMA
checklist for reporting systematic reviews [26].
Methods
Eligibility criteria
Design and population
We included published, randomized controlled trials
(RCTs) that evaluated collaborative care compared to care
as usual or another active intervention in adult primary
care patients with an anxiety disorder and that reported
outcomes on a standardized scale for anxiety severity.
Both individually randomized and cluster randomized tri-
als were included.
Studies had to include adult (>18 years) subjects re-
cruited in a primary care setting with an anxiety disorder
as established with a valid diagnostic interview, according
to research diagnostic criteria, or with a cut-off score on a
validated scale. Comorbid medical or psychiatric condi-
tions were allowed, as long as the intervention focused on
the anxiety disorder.
Intervention and comparison intervention
Collaborative care interventions were defined by the appli-
cation of criterion 1 in combination with criterion 2 and/
or 3 [14, 16–18]:
1. The primary care physician is supported by at least one
other professional with a different field of expertise (e.g.
care manager, consultant psychiatrist), and they work
together in providing care for the patient.
2. Evidence-based treatment is provided.
3. Process and outcome of treatment is monitored.
Studies evaluating the provision of services by an on-site
mental health professional were excluded, unless reference
was made to enhanced collaboration between the primary
care physician and the mental health professional. Collab-
oration between professionals had to be ensured by team
meetings, consultation or supervision, or a digital commu-
nication system. The collaborative care intervention could
be compared to care as usual, a waitlist condition, or an-
other active intervention.
Outcomes
Studies that reported outcomes at follow-up closest to
12 months on a validated continuous anxiety scale or
dichotomous interview (indicating response or remis-
sion) were included. Standardized scales or interviews
could measure general anxiety (across anxiety disorders)
or measure a specific type of anxiety (e.g. panic disorder
severity).
Search strategy and selection criteria
We searched PubMed (Medline), Psycinfo, Embase, The
Cochrane Central Register of Controlled Trials, and Cinahl
from inception to March 10th 2014 without language
restriction. The highly sensitive search was performed by
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an experienced librarian and author A.M., combining terms
related to anxiety, primary care, and randomized controlled
trials. For Medline, we used free text words and MeSH
terms such as “Anxiety”, “Anxiety Disorders”, “Primary
Health Care” and “Family Practice”. We combined these
with a pre-tested search string for randomized controlled
trials. See Fig. 1 for the full search strategy as performed in
PubMed, which was adapted for use in the other databases.
The reference lists of selected randomized controlled trials
(RCTs) and reviews were checked for potentially relevant ti-
tles. The search was limited to published studies.
Study selection
Titles and abstracts of retrieved studies were screened inde-
pendently by two reviewers (AM/CFC) using a list of inclu-
sion criteria. If a study appeared eligible (or if eligibility was
doubtful), the full text of an article was retrieved. All full-
text articles were assessed for eligibility by two independent
Fig. 1 PubMed Search History for randomized controlled trials examining the effects of collaborative care for adult primary care patients with an
anxiety disorder, compared to care as usual or another intervention
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reviewers (AM and AvB/HvM/CFC). Disagreement was
resolved by consensus or a third reviewer. The outcome
data were extracted by two reviewers independently (AM
and CFC). Other relevant characteristics of studies were
extracted by one author (AM) using a form based on
Cochrane criteria [27] (see Table 1).
Data collection process
We extracted sample size, means, and standard deviations
for scores on anxiety scales at baseline and follow-up for
the intervention group and the control group. Outcomes
for anxiety disorders in general as well as outcomes for
specific anxiety disorders were extracted. For studies using
more than one validated anxiety scale as an outcome
measure, we chose the reported primary outcome meas-
ure. If the mean and standard deviation were not reported,
we searched for other data necessary to calculate an effect
size, such as a difference score with a standard deviation
or confidence limits, and p-value [27]. Furthermore, data
relevant for the interpretation of the findings such as the
setting, diagnoses, the interventions used and the profes-
sionals involved were collected (see Table 1). Where
published protocols of the studies included were available,
they were used to supplement data about intervention
details.
Risk of bias in individual studies
The risk of bias of each included study was assessed
using a standard form based on Cochrane criteria [28]
by two reviewers (AM and AvB/HvM) independently.
The form systematically enquired about possible sources of
bias in randomized controlled trials, such as the adequacy
of the randomization procedure, allocation concealment,
handling of missing data and selective reporting. Disagree-
ment between reviewers about assessment ratings were
resolved by consensus or a third reviewer (CFC).
Synthesis of results
We statistically summarized the effectiveness of collabora-
tive care interventions versus the comparison interventions
using meta-analysis. The analyses were conducted using
the software package Comprehensive Meta Analysis version
2.0 [29]. We calculated a standardized mean difference
(SMD) from reported differences in means on a continuous
anxiety scale between interventions at 12 months follow-
up. We summarized the SMDs using the random effects
model [30]. To assess the heterogeneity among studies, we
calculated the I2 statistic, which reflects the proportion of
total variation across studies that is attributable to hetero-
geneity rather than chance. An I2 of 0 % means that there is
no observed heterogeneity, while an I2 of 25, 50 and 75 %
may be interpreted as low, medium, and high heterogeneity
respectively [31].
Risk of bias across studies
Funnel plots were created and Duval and Tweedie’s trim
and fill method was used to examine the possibility of
publication bias [32]. This method gives an estimate of the
effect size after correcting for possible publication bias.
Additional analyses
A predefined subgroup analysis was performed to assess
the effectiveness of collaborative care for patients with a
specific anxiety disorder. A disorder-specific outcome
measure (if available) was used to calculate the effect
size in a random effects meta-analysis. In an additional
subgroup analysis, we examined several variables related
to study procedures and intervention details based on the
meta-regression of Coventry and colleagues [25]. We omit-
ted variables described by Coventry and colleagues that
were not present in any of the included studies and added
the element of stepped care as this was a prominent aspect
of studies 6 and 7 [21, 22]. For this subgroup analysis, we
used a mixed-effects model which pools studies in a sub-
group using a random effects model. In addition, we used a
fixed-effects model to interpret variance between studies
(Q and I2) and to test for significant differences between
subgroups.
Results
Study selection
The literature search resulted in a total of 4929 retrieved
citations. After removal of duplicates, 3073 abstracts were
available (see Fig. 2). Main reasons for exclusion of studies
based on titles or abstracts were no RCT, no inclusion of
anxiety disorders and no collaborative care. For 20 studies
the full-text paper was retrieved and examined for inclu-
sion. After the exclusion of 13 studies (nine no collabora-
tive care; three no separate outcome reported for patients
with anxiety disorders; one report of other study), there
were seven studies that met all inclusion criteria.
Study characteristics
Seven studies involving 2105 participants (1107 in the col-
laborative care condition, 998 in the control condition)
were included: Roy-Byrne et al. 2001 [33] (study 1); Roy-
Byrne et al. 2005 [34] (study 2); Rollman et al. 2005 [35]
(study 3); König et al. 2009 [36] (study 4); Roy-Byrne et al.
2010 [37] (study 5); Oosterbaan et al. 2013 [21] (study 6);
and Muntingh et al. 2014 [22] (study 7). Table 1 shows an
overview of characteristics of the included studies.
Design and participants
The number of participants in each study ranged from
57 to 1004. Of the trials, four were individually random-
ized controlled trials (study 1–3, 5); three used cluster
randomization on the level of primary care practices
(study 4, 6, 7); four were conducted in the USA (studies
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Table 1 Characteristics of randomized controlled trials comparing collaborative care for anxiety disorders with care as usual
Study
No.
Authors/
year
De-sign Recruit-ment Diagn
instr.
Int. Setting N
(ITT)
Collaborative care
intervention
Professionals
involved
Comparison
intervention
Outcomes FU Outcome CC
vs CAU
Outcome at
12 months
[95 % CI]
1 Roy-Byrne
et al. 2001
(Study 1)
RCT Referral
Screening
(waiting
room,
PHQ-2 PD)
PD
CIDI
CC
vs
CAU
3 primary
care
clinics
(US)
CC:
57
CAU:
58
Medication
management by
psychiatrist
PCP,
psychiatrist
CAU by PCP, i.e.
pharmacotherapy
or referral to mental
health professional
ASI, PDSS
3,6,9,12
months
-Improved
anxiety
outcome
at 3,6 and
12 months
-Improved
panic outcome
at 6 months
-Anxiety/panic (ASI):
T = 2.14, p = 0.035
ES 0.45 [0.03-0.87]
-Panic (PDSS):
statistics continuous
outcome not reported
2 Roy-Byrne
et al. 2005
(Study 2)
RCT Referral
Screening
(waiting
room,
PHQ-2 PD)
PD
CIDI
CC
vs
CAU
University
affiliated
primary
care
clinics
(US)
CC:
119
CAU:
113
CBT and/or
antidepressant
medication
PCP, CM,
psychiatrist
CAU by PCP, i.e.
pharmacotherapy
or referral to mental
health professional
ASI
3,6,9,12
months
-Improved
anxiety/panic
outcome at all
time points
- Anxiety/panic (ASI):
Dif −6.64
[−10.73 to −2.48]
p <0.001;
ES 0.48 [0.18-0.78]
3 Rollman et
al. 2005
(Study 3)
RCT Screening
(waiting
room, PHQ)
PD/
GAD
PRIME-
MD
CC
vs
CAU
4
university
affiliated
primary
care
practices
(US)
CC:
116
CC:
75
Guided selfhelp
and/or
antidepressant
medication and/
or referral to
mental health
specialist
PCP, CM,
psychiatrist/
Psycho-
therapist
CAU by PCP and
patients received a
diagnosis specific
brochure
SIGH-A,
PDSS
2,4,8,12
months
-Improved
anxiety
outcome at
12 months
- Improved
panic
outcomes at
12 months
-No sign.
improvement
in GAD
outcomes
-Anxiety (SIGH-A):
Dif −3.6 [ −6.4 to −0.8]
p = 0.01;
ES 0.43 [0.10-0.77]
-Panic (PDSS):
Diff −3.3 [−5.5 to −1.1]
p = 0.004;
ES 0.58 [0.19-0.97]
-GAD (SIGH-A):
Diff −1.1 [−5.0 to 2.7]
p = 0.57;
ES 0.13 [−0.32 to 0.58]
4 Konig et al.
2009
(Study 4)
Clus-ter
RCT
Screening
(PHQ)
PD/
GAD/
any
AD
PHQ
CC
vs
CAU
46
primary
care
practices
(GER)
CC:
201
CAU:
188
Counselling (CBT)
by the PCP
PCP,
psychiatrist/
Psycho-
therapist
CAU by PCP, including
referral to mental
health professional
BAI
6,9 months
- No difference
in anxiety
outcomes
-Anxiety (BAI):
CC: M 18.18 SD 12.17
CAU: M 16.72 SD 10.34,
p = 0.35;
ES −0.13 [−0.36-0.10]
5 Roy-Byrne
et al. 2010
(Study 5)
RCT Referral PD/
GAD/
SOP/
PTSD
MINI
CC
vs
CAU
17
primary
care
clinics
(US)
CC:
503
CAU:
501
CBT and/or
antidepressant
medication
PCP, CM,
psychiatrist
CAU by PCP, i.e.
medication,
counseling or referral
to mental health
professional
BSI, PDSS,
GADSS, SPIN,
PCL
6,12,18 months
-Improved
anxiety
outcome at all
time points
-Improved
panic outcome
at 6 and
12 months
-Improved
GAD outcome
at all time
points
-Improved SOP
outcome at 6
-Anxiety (BSI):
Diff −2.63 [ −3.73
to −1.54] p <0.001;
ES 0.33 [0.19-0.47]
-Panic (PDSS):
Diff −2.71 [ −4.29
to −1.14] p = .003;
ES 0.48 [0.20-0.76]
-GAD (GADSS):
Diff −2.34 [−3.22
to −1.45] p <0.001;
ES 0.49 [0.30 to 0.68]
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Table 1 Characteristics of randomized controlled trials comparing collaborative care for anxiety disorders with care as usual (Continued)
and
12 months
-No sign.
improvement
in PTSD
outcomes
-SOP (SPIN): Diff −5.71
[−10.74 to −0.68] p = 0.08;
ES 0.43 [0.05 to 0.81]
- PTSD (PCL-C): Diff −7.7
[−17.55 to 2.15] p = 0.49;
ES 0.45 [−0.12 to 1.02]
6 Oosterbaan
et al. 2013
(Study 6)
Clus-ter
RCT
Referral PD/
AGO/
GAD/
SOP/
SP
MINI
CC
vs
CAU
22
primary
care
practices
(NL)
CC:
28
CAU:
27
Step 1) CBT
based guided
self-help with
antidepressant
medication for
moderate
disorder
Step 2) CBT and
medication in
specialty care
PCP, CM,
psychiatrist,
CBT
therapist
CAU by PCP, i.e.
medication,
counseling or referral
to mental health
professional
CGI-I, CGI-S,
HRS-A
4,8,12 months
-Improved
anxiety
outcomes at
4 months
-Anxiety (HRS-A)
CC: M 6.14 SD 5.26
CAU M: 8.11 SD 7.83
p = 0.02
ES 0.29 [−0.29 to 0.87]
7 Muntingh
et al. 2014
(Study 7)
Clus-ter
RCT
Referral
Screening
(PHQ)
PD/
GAD
MINI
CC
vs
CAU
43
primary
care
practices
(NL)
CC:
114
CAU:
66
Step 1) CBT
based guided
self-help
Step 2) CBT
Step 3)
antidepressant
medication
PCP, CM,
psychiatrist,
CBT
therapist
CAU by PCP, i.e.
medication,
counseling or referral
to mental health
professional (including
CM randomized to
CAU)
BAI -Improved
anxiety
outcome at all
time points
-Improved
panic outcome
at all time
points
-No sign.
improvement
in GAD
outcomes
-Anxiety (BAI)
Diff −6.84 [ −10.13
to −3.55]
p <0.001;
ES 0.73 [0.37-1.09]
- PD (BAI):
Diff −9.29 [−12.99
to −5.59]
ES 1.03 [0.60 to 1.46]
- GAD (BAI):
Diff −1.13 [−7.33 to 5.08]
p = 0.72
ES 0.13 [−0.56 – 0.81]
Abbreviations: AD anxiety disorder, ASI anxiety sensitivity index, BAI Beck Anxiety Inventory, CAU care as usual, CBT cognitive behavioral therapy, CC collaborative care, CI confidence interval, CIDI Composite
International Diagnostic Interview, CM care manager, ES effect size, GAD generalized anxiety disorder, GADSS Generalized Anxiety Disorder Severity Scale, GER Germany, HRS-A Hamilton Rating Scale for Anxiety, ITT
intention to treat, MINI Mini-International Neuropsychiatric Interview, NL Netherlands, PD Panic disorder, PCL-C PTSD Checklist–Civilian Version, PCP primary care physician, PDSS panic disorder severity scale, PHQ Patient
Health Questionnaire, PRIME-MD Primary Care Evaluation of Mental Disorders, PTSD post traumatic stress disorder, SIGH-A Hamilton Anxiety Rating Scale, SOP social phobia, SP specific phobia, SPIN Social Phobia Inven-
tory, US United States
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1–3,5), one in Germany (study 4) and two in the
Netherlands (study 6 and 7). All studies reported that
their study protocol was approved by the relevant
medical ethical committee (Study 4, 6 and 7) or the
institutional review board (study 1–3, and 5). Two
studies exclusively included patients with panic dis-
order (studies 1 and 2), two studies (studies 3 and 7)
included patients with panic disorder and/or general-
ized anxiety, and three studies (studies 4–6) included
multiple anxiety disorders. Comorbid depression was
allowed in all studies and was reported in five studies
(Study 1–3, 5, 7), with prevalence rates ranging from
31 % (Study 7) to 64 % (Study 5). With one exception,
studies used a structured interview to classify the anx-
iety disorder at baseline (CIDI, PRIME-MD). König
and colleagues (study 4) determined the presence of
an anxiety disorder by a cut-off score on the Patient
Health Questionnaire. To recruit participants, two
studies used screening only (studies 3 and 4), two
studies (studies 5 and 6) used referral of primary care
physicians, while three studies used both methods
(studies 1,2,7).
Collaborative care and comparison interventions
The content of collaborative care interventions varied
considerably between studies. In all studies, a primary
care physician and a psychiatrist were involved, while
in five studies a care manager was introduced as well
(studies 2,3,5–7). One study used only medication man-
agement by a psychiatrist (study 1) and one study eval-
uated counselling with CBT elements by a trained
primary care physician (study 4). The other studies
used more comprehensive programs with a choice be-
tween, or combination of, antidepressant medication
and CBT. Two studies (studies 6 and 7) used a stepped
care program. Table 2 describes the characteristics of
collaborative care in the included studies.
All studies compared the collaborative care inter-
vention to usual care coordinated by the primary care
physician. Table 3 gives an overview of the percentage
of patients receiving pharmacotherapy, appropriate
pharmacotherapy, counseling, CBT, and (specialized)
mental healthcare as reported in the included studies.
Pharmacotherapy was the most frequent treatment
method reported in usual care.
Fig. 2 PRISMA flowchart [50]
Muntingh et al. BMC Family Practice  (2016) 17:62 Page 7 of 15
Table 2 Characteristics of collaborative care interventions for anxiety disorders
Study
no.
Study
(first author,
year)
Professionals
involved
Professional training Interventions used No. contacts
with
professionals
Collaboration
between
professionals
Monitoring Follow-up /
relapse
prevention
1 Roy-Byrne
et al. 2001
PCP
Psychiatrist
PCP: 1-h didactic,
medication
algorithm
Medication management
(paroxetine) and encouragement
of adherence and exposure by
psychiatrist
Educational patient video
2 visits and 2
phone calls by
psychiatrist
The PCP received a typed
consultation note after each
psychiatric visit.
No information
provided
5 follow-up calls by
psychiatrist
2 Roy-Byrne
et al. 2005
PCP,
Psychiatrist
CM
PCP: 1-h didactic
on, medication algorithm
CM: treatment protocol,
six videotapes, 1 day long
workshop in care
management and CBT
Face-to-face CBT
Antidepressant medication
according to algorithm by PCP
Educational video and workbook
6 sessions by
CM
Weekly caseload supervision of
CM by psychiatrist
2-way communication of CM
and PCP by telephone, fax, and
e-mail.
Recommendations as needed
from a consulting psychiatrist
to the PCP via the CM
No information
provided
Intended were 6
telephone follow-up
contacts during
10 months after the
active treatment
phase by CM
3 Rollman et
al. 2005
PCP,
Psychiatrist
CM
PCP: 1-h conference and in
dividual meeting of study
investigators with PCPs,
medication algorithm
CM: study protocol and
self-management workbooks,
attending lectures at the
University
CBT based guided self-help
Antidepressant medication
according to algorithm by PCP
Referral to a community mental
health specialist
7 telephone
contacts by
CM
Weekly caseload supervision of
CM by psychiatrist
Advice from the psychiatrist to
the PCP and patient via CM
Communication facilitated
through an ambulatory EMR
system
Monitoring by
CM with PDSS /
GADSS
Telephone contacts
every 1–3 months
after the acute phase
to monitor symptoms
4 König et
al.2009
PCP,
Psychiatrist/
Clinical
psychologist
PCP: 10 h training and two
additional sessions on
counseling skills and CBT
Counseling by PCP, including
CBT techniques
No information
provided
As needed consultation
by psychiatrist/clinical
psychologist at PCPs’
practices
No information
provided
No information
provided
5 Roy-Byrne
et al. 2010
PCP,
Psychiatrist
CM
PCP: single-session training,
medication algorithm
CM: treatment protocol, 6
half days of didactics in care
management and CBT
Face-to-face CBT by CM
supported by computer program
Antidepressant medication
according to algorithm by PCP
6–8 sessions
by CM
Weekly caseload supervision
of CM by psychiatrist/psychologist
“Regular” interaction between
PCP and CM in person and by
telephone
As needed consultation of PCP
by psychiatrist
Communication facilitated
through a webbased
monitoring system
Monitoring with
OASIS by CM
Monthly follow-up
telephone calls by
CM
6 Oosterbaan
et al. 2013
PCP
Psychiatrist/
CBT specialist
CM
PCP: one educational session,
medication algorithm
CM: treatment protocol,
2-day training session in
basic CBT strategies
Stepped care (according
to severity):
1. CBT based guided self-help
with support by CM (face-to-
face) with antidepressant
medication according to
algorithm by PCP for patients
with a moderate disorder
2. CBT and antidepressants in
specialised mental health service
Step 1: 5 sessions
by CM
Step 2: No
information
provided
2-weekly supervision of CM by
CBT specialist
As needed consultation of PCP
by psychiatrist
Monitoring with
CGI by CM
No information
provided
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Table 2 Characteristics of collaborative care interventions for anxiety disorders (Continued)
7 Muntingh
et al. 2014
PCP
Psychiatrist/
CBT specialist
CM
PCP: 3 h workshop,
medication algorithm
CM: treatment protocol,
3-day workshop in care
management and CBT
strategies
Stepped care:
1. CBT based guided
self-help with support
by CM (face-to-face)
2. CBT by CM
3. Antidepressant medication
according to algorithm
by PCP
Step 1: 5 sessions
by CM
Step 2: 6 sessions
by CM
Intended was 3-weekly
supervision of CM by
psychiatrist/
CBT specialist
GP and CM were “instructed
to frequently discuss
treatment progress”
As needed consultation
of PCP by psychiatrist
Monitoring with
BAI by CM
Monthly follow-up
telephone calls
by CM
Abbreviations: CBT cognitive behavioral therapy, CM care manager, PCP primary care phyisican
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Outcome measures
All studies included a continuous outcome scale to meas-
ure anxiety. Study 2 used a dichotomous outcome (remis-
sion and response) as primary outcome measure. Five
studies reported separately about panic disorder outcomes
(studies 1–3,5,7). The length of follow-up varied from
9 months (study 4) to 18 months (study 5). Two studies
(studies 4 and 7) used patient self-report to assess the out-
come, while in the other five studies a (blinded) research
assistant administered the outcome measures by telephone.
Risk of bias within studies
The overall quality of included studies was moderate to high
(see Table 4). For study 1, six out of eight criteria were rated
as unclear; in the other studies four to six criteria were rated
as low risk of bias. The most prevalent potential source of
bias was the inability to blind patients and professionals for
treatment allocation, as is common in psychotherapy
research [38]. Studies 6 and 7 used cluster randomization
with subsequent referral by the primary care physician,
which may have induced selection bias. Study 1 did not pro-
vide the statistics of an insignificant result on the Panic Dis-
order Severity Scale (PDSS). Of four studies (studies 2,3,5,
7), a published study protocol was retrieved [39–42].
Results of individual studies
The results of the individual studies at follow-up closest to
12 months are reported in Table 1. All studies except
study 4 reported a significantly greater effect of the collab-
orative care intervention compared to care as usual. The
meta-analysis (Fig. 3), pooling the data of all seven studies,
yielded an SMD of 0.35 (95 % CI 0.14 to 0.56, p = 0.001),
indicating that collaborative care leads to a significantly
greater reduction in anxiety symptoms, with a small
effect size after 12 months. The Q-value was 21.73
(df = 6, p = 0.001), indicating significant dispersion across
Table 4 Risk of bias in 7 randomized controlled trials comparing collaborative care for adult patients with anxiety disorders to usual
primary care
Adequate
Sequence
Generation?
Allocation
concealed?
Patients
blinded?
Professionals
blinded?
Outcome
assessors
blinded?
Incomplete
outcome
data addressed?
Free of selective
reporting?
Free of
other bias
Roy-Byrne et al. 2001 + ? ? ? + ? ? ?
Roy-Byrne et al. 2005 ? + – – + + ? +
Rollman et al. 2005 + + – – + + ? +
König et al. 2009 + + – – ? + ? +
Roy–Byrne et al. 2010 + + ? – + + + +
Oosterbaan et al. 2013 + + – – + + + +
Muntingh et al. 2014 + + – – + + + +
Table 3 Care received in the collaborative care and care as usual conditions (N = 7)
Content of care* Pharmaco-therapy (%) Approriate pharmaco-
therapy (%)
Counseling (%) CBT (%) Referral to mental
health professional (%)
Study CC CAU CC CAU CC CAU CC CAU CC CAU
Roy-Byrne et al. 2001* 77 %a 48 %a 47 %b 33 %b NA NA NA NA NA 25 %
Roy-Byrne et al. 2005 54 %c 52 %c 41 %b 39 %b 70 % 34 % 63 %d 14 %d NA NA
Rollman et al. 2005 77 %e 66 %e NA NA 79 %f NA 66 %g NA 18 % 26 %
König et al. 2009 NA NA NA NA NA NA NA NA 33 % 33 %
Roy-Byrne et al. 2010 70 %h 68 %h 46 %i 42 %i 88 % 51 % 82 %j 34%j NA NA
Oosterbaan et al. 2013* 45 % 33 % NA NA NA NA 75 %g NA NA NA
Muntingh et al. 2014 21 %e 35 %e NA NA 92 % 12 % 78 %g NA 11 % 21 %
*Highest % of patients that have received a form of care at any follow-up measurement
aAppropriate type of medication
bAdequate dose and duration of medication
c Any antipanic pharmacotherapy
d3 or more sessions counseling plus at least 4 of 7 CBT techniques
eSSRI/SNRI pharmacotherapy
f3 or more telephone contacts with CM
g3 or more (telephone) contacts with CM about CBT workbook
hAny psychotropic medication
IAppropriate type, dose and duration
jCounseling with at least 3 CBT elements
NA = Not Available
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studies. The I2 was 72 %, which indicates that a high
proportion of the total variation may be attributed to true
heterogeneity between studies. A sensitivity analysis ex-
cluding Study 4 led to a considerable decrease in hetero-
geneity (Q = 4.72, df = 5, p = 0.34; I2 = 0 %) and a higher
SMD (SMD= 0.40, 95 % CI 0.30 to 0.51, p < 0.001).
Risk of bias across studies
The funnel plot showed an indication (not significant) for
publication bias for the analysis on all anxiety disorders
(Egger’s test, two-tailed p = 0.57). According to the trim
and fill method [32], the SMD should be adjusted from
0.35 to 0.25 (95 % CI 0.16 to 0.34). This asymmetry may
indicate that the effect of collaborative care for anxiety
disorders is slightly overestimated due to publication bias,
although asymmetry may also be attributed to true hetero-
geneity between studies [43]. Indeed, heterogeneity was
high (I2 = 72 %), which may be attributed to differences
between the three European studies (I2 = 78 % in European
studies vs. I2 = 0 % in US studies). For the subgroup analysis
on panic disorder, no indication was found for a publication
bias (Egger’s test, two-tailed p = 0.29). Furthermore, we ran
a sensitivity analysis excluding the lowest quality study
(Study 1). This had no significant effect on the analysis on
anxiety disorders (SMDadjusted 0.34, 95 % CI 0.10 – 0.58) or
panic disorder (SMDadjusted 0.60, 95 % CI 0.38 to 0.83).
Additional analysis: disorder-specific impact of collaborative
care
A predefined subgroup analysis was performed for pa-
tients with panic disorder. Outcomes on the Panic Dis-
order Severity Scale (PDSS) were used when reported.
For the two studies (2,7) that did not report the PDSS,
the primary outcome measure was used in the meta-
analysis. Because Roy-Byrne and colleagues [33] reported
an insignificant result on the PDSS, but were not able to
provide the statistics necessary for calculating the effect
size, we used the ASI score. The combined effect size of
the four studies comparing collaborative care to care as
usual in patients with panic disorder was 0.59 (95 % CI
0.41 to 0.78, p < 0.001), which may be interpreted as a
moderate effect size (Fig. 4).
Fig. 3 Meta-analysis for the effect of collaborative care vs. care as usual on continuous anxiety scales at 12 months follow-up
Fig. 4 Subgroup-analysis for the effect of collaborative care vs. care as usual at 12 months follow-up for patients with a panic disorder
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Concerning anxiety disorders other than panic disorder,
studies 3 and 7 reported no significant effect for patients
with generalized anxiety disorder only (Table 1). Study 5 re-
ported a significant difference between collaborative care
and care as usual on the Brief Symptom Inventory (BSI) for
panic disorder, generalized anxiety disorder, and social pho-
bia, but not for posttraumatic stress disorder (PTSD). In a
subsequent report on this study [44], disorder-specific data
on specific scales were reported, with similar results
(Table 1).
Additional analysis: variables related to outcome
Additional analyses were performed to assess the impact
on outcome of variables related to study procedure and
content of the intervention (see [25]; Table 5). The ana-
lysis revealed that studies performed in the United States
were more homogeneous (I2 = 0 % vs. 87 %) and on aver-
age yielded a significantly greater effect size than studies
performed in European countries (SMD 0.37 vs. 0.29, p
= 0.03). Furthermore, the five studies that included a
care manager had a significantly higher effect size (SMD
0.42 vs. 0.13, p = 0.001) than those without. Lastly, the
two studies using stepped collaborative care (both from
the Netherlands) yielded a greater effect size than stud-
ies that did not use stepped care (SMD 0.57 vs. 0.29, p =
0.04). However, these analyses need to be interpreted
with caution due to the small number of studies and the
considerable heterogeneity between European studies.
Discussion
Summary of evidence
The results of this meta-analysis indicate that collaborative
care is more effective than usual primary care at twelve
months follow-up, with a small effect size for all anxiety
disorders combined (SDM 0.35) and a moderate effect size
for patients with panic disorder (SMD 0.59). The quality
of studies was moderate to high. There were indications
for considerable heterogeneity between European studies
in contrast to studies performed in the United States.
Strengths and limitations
A strength of this study is that we conducted this review
using PRISMA criteria [26]. Furthermore, we were able to
Table 5 Meta-analysis with between-study subgroup analyses of variables related to study procedures and content of collaborative care
Covariate Number SDM 95% CI Q I2 P
All studies 7 0.35 0.14 – 0.56 21.73 72.39
Country 0.031*
US 4 0.37 0.26 – 0.49 1.10 0.00
European 3 0.29 −0.31 – 0.89 15.98 87.50
Randomization procedure 0.031*
Patient randomization 4 0.37 0.26 – 0.49 1.10 0.00
Cluster randomization 3 0.29 −0.31 – 0.89 15.98 87.50
Recruitment method 0.65
Referral by professional 2 0.33 0.19 – 0.47 0.02 0.00
Systematic identification (or both) 5 0.38 0.05 – 0.71 21.51 81.41
Care manager 0.001*
Care manager 5 0.42 0.29 – 0.55 4.66 14.24
No care manager 2 0.13 −0.43 – 0.70 5.69 82.43
Intervention content 0.82
Psychological intervention (CBT) with/without medication management 5 0.42 0.29 – 0.55 4.66 14.24
Medication management alone 1 0.45 0.03 – 0.87 – –
Not applicable 1 – – – –
Stepped care 0.041*
Stepped care 2 0.57 0.06 – 0.53 1.58 36.85
No stepped care 5 0.29 0.16 – 0.99 15.97 74.95
Supervision frequency specialist-care manager 0.056
Ad hoc 1 0.73 0.37 – 1.09 – –
Scheduled (i.e. at least 2-weekly) 4 0.36 0.25 – 0.48 1.03 0.00
Not applicable 2 – – – –
*p<0.05
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examine the long-term effects of collaborative care, which
is often problematic in reviewing effectiveness studies on
anxiety disorders in primary care [45]. However, there are
several limitations in this systematic review and meta-
analysis that need consideration.
We identified only seven studies that met our inclusion
criteria. As our search was limited to published articles,
we probably have missed (unpublished) RCTs, which
generally report lower effect sizes [46]. For example, we
omitted a study by Rollman and colleagues [47], including
250 patients with generalized anxiety disorder or panic
disorder, because their results remain unpublished. They
reported an effect size of 0.30 in a conference abstract,
which is comparable to the overall effect size found in our
meta-analysis.
Furthermore, some methodological issues should be
mentioned. One study [33] did not report the statistics for
the insignificant effect on the disorder-specific measure.
However, a sensitivity analysis excluding this study did not
alter the results. Also, two studies [21, 22] used referral as
a recruitment method after cluster randomization, which
may cause selection bias and inflated effect sizes [48]. Yet
Muntingh and colleagues, who used both referral and
screening to recruit patients, reported nearly equal effect
sizes in a subgroup analysis on patients selected by
screening [22]. Lastly, one may debate on the broad
concept of collaborative care. The seven studies that
fulfilled our inclusion criteria varied on several charac-
teristics, such as the inclusion of a care manager, care
manager supervision, provision of CBT, and following a
stepped care protocol. Common elements in all seven
studies were the input of specialist mental health in pri-
mary care, collaboration between professionals and the
provision of evidence based interventions. As we are
coming closer to defining the most effective elements
of collaborative care (such as the provision of psycho-
logical treatment by a care manager [25]), the concept
of collaborative care can be refined in the future, lead-
ing to more homogeneous results.
Comparison with the literature
The results from our meta-analysis compare to those
reported in previous meta-analyses on collaborative care
for anxiety disorders [19, 20] and extend their results
with the inclusion of recent European and collaborative
stepped care studies. The SMD of 0.35 found in our
meta-analysis is also similar to the SMD of 0.28 which
was reported in two large meta-analyses about collabora-
tive care for depressive disorders [19, 25].
Comorbid depression was prevalent in the included
studies (31–64 %). Unfortunately, none of the studies
reported on the effects of comorbid depression on out-
come, while depression has been related to a poor out-
come of treatment for anxiety disorders [49].
We found that studies performed in the US had a
greater effect size compared to European studies, which
is in contrast with previous findings [25]. The US studies
were also considerably more homogeneous than the
European studies, which may be related to similarities
and differences in healthcare systems between the US
and Europe [16]. The studies in the US were mainly con-
ducted in large clinics (often university-affiliated) using
specifically trained and employed care managers, which
may have facilitated effective implementation of the
intervention, while the European studies were performed
in more diverse settings in rather small primary care
practices with collaborating professionals who were only
involved in collaborative care on a part-time basis [21].
However, the heterogeneity between the European stud-
ies may also be related by other study characteristics
such as design and intervention details. In fact, the study
of König and colleagues [36] was the only study to re-
port a non-significant effect of the intervention, and ex-
cluding this study from the analysis led to a considerable
decrease in heterogeneity. The absence of a significant
effect of this study could be related to a) suboptimal
implementation and b) the fact that they employed the
most ‘basic’ package of collaborative care. Both careful
implementation and the application of a comprehensive
collaborative care program may thus be crucial to the
effectiveness of collaborative care. Including the study of
König and colleagues probably provides a conservative
estimate of the effects of collaborative care for anxiety
disorders. In any case, compared to psychological treat-
ment alone for anxiety disorders in primary care [45],
the results of collaborative care are promising.
Implications for research
Most importantly, more randomized controlled trials and,
subsequently, individual patient data meta-analyses are war-
ranted to better identify who can benefit from what aspect
of the intervention. We found a somewhat greater effect size
for patients with panic disorder than for all anxiety disorders
combined. In fact, evidence for the effectiveness of collab-
orative care for generalized anxiety disorders based on three
included studies was inconclusive [21, 35, 37], so future re-
search should address the effectiveness of collaborative care
for anxiety disorders other than panic disorder. Further-
more, as described above, successful implementation of the
intervention seems essential for the effectiveness of collab-
orative care. Hence, implementation should also be a focus
of research on collaborative care. Lastly, cost-effectiveness
analyses are needed to increase our knowledge on the bene-
fits of collaborative care.
Conclusions
This meta-analysis indicates that collaborative care is more
effective than usual primary care for adult patients with
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common anxiety disorders (small effect size), and panic
disorder in particular (moderate effect size). Since it is diffi-
cult to improve primary care for anxiety disorders, this is a
promising result. More research is needed to increase diag-
nostic precision, disentangle elements that make collabora-
tive care most effective, and to evaluate the effectiveness of
collaborative care in different anxiety disorders.
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